Download PDF
Semin Thromb Hemost 2013; 39(04): 400-405
DOI: 10.1055/s-0033-1334141
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Thrombolysis for Intraventricular Hemorrhage

Ricky H. Wong
1   Department of Neurosurgery, University of Chicago, Chicago, Illinois
,
Julian E. Bailes
2   Department of Neurosurgery, North Shore Neurological Institute, North Shore University Health System, Evanston, Illinois
› Author Affiliations
Further Information

Publication History

Publication Date:
27 February 2013 (online)

    Permissions and Reprints

Abstract

Intraventricular hemorrhage is a frequent complication of intracerebral hemorrhage and is independently associated with significant morbidity and mortality. Intraventricular fibrinolytic therapy is used with increasing frequency to accelerate clot clearance. We review the recent evidence and discuss the therapeutic benefits as well as the current concerns and limitations of fibrinolytic use in this setting.

Keywords

intraventricular hemorrhage - intracerebral hemorrhage - fibrinolytics - tissue plasminogen activator
 

  • References

  • 1 Hallevi H, Albright KC, Aronowski J , et al. Intraventricular hemorrhage: anatomic relationships and clinical implications. Neurology 2008; 70 (11) 848-852
    CrossrefPubMedGoogle Scholar
  • 2 Dey M, Stadnik A, Awad IA. Thrombolytic evacuation of intracerebral and intraventricular hemorrhage. Curr Cardiol Rep 2009; 11 (1) 4-11
    CrossrefPubMedGoogle Scholar
  • 3 Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 1999; 27 (3) 617-621
    CrossrefPubMedGoogle Scholar
  • 4 Bhattathiri PS, Gregson B, Prasad KS, Mendelow AD. STICH Investigators. Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial. Acta Neurochir Suppl (Wien) 2006; 96: 65-68
    PubMedGoogle Scholar
  • 5 Kramer AH, Mikolaenko I, Deis N , et al. Intraventricular hemorrhage volume predicts poor outcomes but not delayed ischemic neurological deficits among patients with ruptured cerebral aneurysms. Neurosurgery 2010; 67 (4) 1044-1052 , discussion 1052–1053
    CrossrefPubMedGoogle Scholar
  • 6 Hanley DF. Intraventricular hemorrhage: severity factor and treatment target in spontaneous intracerebral hemorrhage. Stroke 2009; 40 (4) 1533-1538
    CrossrefPubMedGoogle Scholar
  • 7 Hallevi H, Walker KC, Kasam M, Bornstein N, Grotta JC, Savitz SI. Inflammatory response to intraventricular hemorrhage: time course, magnitude and effect of t-PA. J Neurol Sci 2012; 315 (1–2) 93-95
    CrossrefPubMedGoogle Scholar
  • 8 Simard PF, Tosun C, Melnichenko L, Ivanova S, Gerzanich V, Simard JM. Inflammation of the choroid plexus and ependymal layer of the ventricle following intraventricular hemorrhage. Transl Stroke Res 2011; 2 (2) 227-231
    CrossrefPubMedGoogle Scholar
  • 9 Pang D, Sclabassi RJ, Horton JA. Lysis of intraventricular blood clot with urokinase in a canine model. Part 3. Effects of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus. Neurosurgery 1986; 19 (4) 553-572
    CrossrefPubMedGoogle Scholar
  • 10 Pang D, Sclabassi RJ, Horton JA. Lysis of intraventricular blood clot with urokinase in a canine model. Part 2. In vivo safety study of intraventricular urokinase. Neurosurgery 1986; 19 (4) 547-552
    CrossrefPubMedGoogle Scholar
  • 11 Pang D, Sclabassi RJ, Horton JA. Lysis of intraventricular blood clot with urokinase in a canine model. Part 1. Canine intraventricular blood cast model. Neurosurgery 1986; 19 (4) 540-546
    CrossrefPubMedGoogle Scholar
  • 12 Hütter BO, Kreitschmann-Andermahr I, Gilsbach JM. Cognitive deficits in the acute stage after subarachnoid hemorrhage. Neurosurgery 1998; 43 (5) 1054-1065
    CrossrefPubMedGoogle Scholar
  • 13 Adams RE, Diringer MN. Response to external ventricular drainage in spontaneous intracerebral hemorrhage with hydrocephalus. Neurology 1998; 50 (2) 519-523
    CrossrefPubMedGoogle Scholar
  • 14 Nieuwkamp DJ, de Gans K, Rinkel GJ, Algra A. Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol 2000; 247 (2) 117-121
    CrossrefPubMedGoogle Scholar
  • 15 Ziai WC, Torbey MT, Naff NJ , et al. Frequency of sustained intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Cerebrovasc Dis 2009; 27 (4) 403-410
    CrossrefPubMedGoogle Scholar
  • 16 Jackson DA, Patel AV, Darracott RM, Hanel RA, Freeman WD, Hanley DF. Safety of intraventricular hemorrhage (IVH) thrombolysis based on CT localization of external ventricular drain (EVD) fenestrations and analysis of EVD tract hemorrhage. Neurocrit Care 2012; (Apr) 28
    PubMedGoogle Scholar
  • 17 Naff NJ, Williams MA, Rigamonti D, Keyl PM, Hanley DF. Blood clot resolution in human cerebrospinal fluid: evidence of first-order kinetics. Neurosurgery 2001; 49 (3) 614-619 , discussion 619–621
    CrossrefPubMedGoogle Scholar
  • 18 Shen PH, Matsuoka Y, Kawajiri K , et al. Treatment of intraventricular hemorrhage using urokinase. Neurol Med Chir (Tokyo) 1990; 30 (5) 329-333
    CrossrefPubMedGoogle Scholar
  • 19 Todo T, Usui M, Takakura K. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase. J Neurosurg 1991; 74 (1) 81-86
    CrossrefPubMedGoogle Scholar
  • 20 Findlay JM, Grace MG, Weir BK. Treatment of intraventricular hemorrhage with tissue plasminogen activator. Neurosurgery 1993; 32 (6) 941-947 , discussion 947
    CrossrefPubMedGoogle Scholar
  • 21 Findlay JM, Weir BK, Stollery DE. Lysis of intraventricular hematoma with tissue plasminogen activator. Case report. J Neurosurg 1991; 74 (5) 803-807
    CrossrefPubMedGoogle Scholar
  • 22 Mayfrank L, Lippitz B, Groth M, Bertalanffy H, Gilsbach JM. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage. Acta Neurochir (Wien) 1993; 122 (1–2) 32-38
    CrossrefPubMedGoogle Scholar
  • 23 Whitelaw A. Endogenous fibrinolysis in neonatal cerebrospinal fluid. Eur J Pediatr 1993; 152 (11) 928-930
    CrossrefPubMedGoogle Scholar
  • 24 King NK, Lai JL, Tan LB , et al. A randomized, placebo-controlled pilot study of patients with spontaneous intraventricular haemorrhage treated with intraventricular thrombolysis. J Clin Neurosci 2012; 19 (7) 961-964
    CrossrefPubMedGoogle Scholar
  • 25 Torres A, Plans G, Martino J , et al. Fibrinolytic therapy in spontaneous intraventricular haemorrhage: efficacy and safety of the treatment. Br J Neurosurg 2008; 22 (2) 269-274
    CrossrefPubMedGoogle Scholar
  • 26 Hinson HE, Hanley DF, Ziai WC. Management of intraventricular hemorrhage. Curr Neurol Neurosci Rep 2010; 10 (2) 73-82
    CrossrefPubMedGoogle Scholar
  • 27 Morgan T, Awad I, Keyl P, Lane K, Hanley D. Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir Suppl (Wien) 2008; 105: 217-220
    PubMedGoogle Scholar
  • 28 Staykov D, Wagner I, Volbers B , et al. Dose effect of intraventricular fibrinolysis in ventricular hemorrhage. Stroke 2011; 42 (7) 2061-2064
    CrossrefPubMedGoogle Scholar
  • 29 Findlay JM, Jacka MJ. Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage. Neurosurgery 2004; 55 (3) 532-537 , discussion 537–538
    CrossrefPubMedGoogle Scholar
  • 30 Coplin WM, Vinas FC, Agris JM , et al. A cohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular hemorrhage. Stroke 1998; 29 (8) 1573-1579
    CrossrefPubMedGoogle Scholar
  • 31 Rainov NG, Burkert WL. Urokinase infusion for severe intraventricular haemorrhage. Acta Neurochir (Wien) 1995; 134 (1–2) 55-59
    CrossrefPubMedGoogle Scholar
  • 32 Rohde V, Schaller C, Hassler WE. Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage. J Neurol Neurosurg Psychiatry 1995; 58 (4) 447-451
    CrossrefPubMedGoogle Scholar
  • 33 Varelas PN, Rickert KL, Cusick J , et al. Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator. Neurosurgery 2005; 56 (2) 205-213 , discussion 205–213
    CrossrefPubMedGoogle Scholar
  • 34 Naff NJ, Hanley DF, Keyl PM , et al. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery 2004; 54 (3) 577-583 , discussion 583–584
    CrossrefPubMedGoogle Scholar
  • 35 Tung MY, Ong PL, Seow WT, Tan KK. A study on the efficacy of intraventricular urokinase in the treatment of intraventricular haemorrhage. Br J Neurosurg 1998; 12 (3) 234-239
    CrossrefPubMedGoogle Scholar
  • 36 Naff N, Williams MA, Keyl PM , et al. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke 2011; 42 (11) 3009-3016
    CrossrefPubMedGoogle Scholar
  • 37 Webb AJ, Ullman NL, Mann S, Muschelli J, Awad IA, Hanley DF. Resolution of intraventricular hemorrhage varies by ventricular region and dose of intraventricular thrombolytic: the Clot Lysis Evaluating Accelerated Resolution of IVH (CLEAR IVH) program. Stroke 2012; 43 (6) 1666-1668
    CrossrefPubMedGoogle Scholar
  • 38 Ziai WC, Melnychuk E, Thompson CB, Awad I, Lane K, Hanley DF. Occurrence and impact of intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Crit Care Med 2012; 40 (5) 1601-1608
    CrossrefPubMedGoogle Scholar
  • 39 Huttner HB, Tognoni E, Bardutzky J , et al. Influence of intraventricular fibrinolytic therapy with rt-PA on the long-term outcome of treated patients with spontaneous basal ganglia hemorrhage: a case-control study. Eur J Neurol 2008; 15 (4) 342-349
    CrossrefPubMedGoogle Scholar
  • 40 Staykov D, Huttner HB, Struffert T , et al. Intraventricular fibrinolysis and lumbar drainage for ventricular hemorrhage. Stroke 2009; 40 (10) 3275-3280
    CrossrefPubMedGoogle Scholar
  • 41 Ramakrishna R, Sekhar LN, Ramanathan D , et al. Intraventricular tissue plasminogen activator for the prevention of vasospasm and hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurgery 2010; 67 (1) 110-117 , discussion 117
    CrossrefPubMedGoogle Scholar
  • 42 Gaberel T, Magheru C, Parienti JJ, Huttner HB, Vivien D, Emery E. Intraventricular fibrinolysis versus external ventricular drainage alone in intraventricular hemorrhage: a meta-analysis. Stroke 2011; 42 (10) 2776-2781
    CrossrefPubMedGoogle Scholar
  • 43 Staykov D, Bardutzky J, Huttner HB, Schwab S. Intraventricular fibrinolysis for intracerebral hemorrhage with severe ventricular involvement. Neurocrit Care 2011; 15 (1) 194-209
    CrossrefPubMedGoogle Scholar
  • 44 Gubucz I, Kakuk I, Major O , et al. [Effectiveness and safety of intraventricular fibrinolysis in secondary intraventricular hemorrhages (a prospective, randomized study)]. Orv Hetil 2004; 145 (31) 1609-1615
    PubMedGoogle Scholar
  • 45 Dunatov S, Antoncic I, Bralic M, Jurjevic A. Intraventricular thrombolysis with rt-PA in patients with intraventricular hemorrhage. Acta Neurol Scand 2011; 124 (5) 343-348
    CrossrefPubMedGoogle Scholar
  • 46 Herrick DB, Ziai WC, Thompson CB, Lane K, McBee NA, Hanley DF. Systemic hematologic status following intraventricular recombinant tissue-type plasminogen activator for intraventricular hemorrhage: the CLEAR IVH Study Group. Stroke 2011; 42 (12) 3631-3633
    CrossrefPubMedGoogle Scholar
  • 47 Lozier AP, Sciacca RR, Romagnoli MF, Connolly Jr ES. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery 2008; 62 (Suppl. 02) 688-700
    PubMedGoogle Scholar
  • 48 Wang YC, Lin CW, Shen CC, Lai SC, Kuo JS. Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose-effect relationship. J Neurol Sci 2002; 202 (1–2) 35-41
    CrossrefPubMedGoogle Scholar
  • 49 Ducruet AF, Hickman ZL, Zacharia BE , et al. Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage. Neurosurgery 2010; 66 (4) 648-655
    CrossrefPubMedGoogle Scholar
  • 50 Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest 2003; 112 (10) 1533-1540
    CrossrefPubMedGoogle Scholar
  • 51 Findlay JM, Weir BKA, Gordon P, Grace M, Baughman R. Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm. Neurosurgery 1989; 24 (4) 491-498
    CrossrefPubMedGoogle Scholar